300396.SZ
ST迪瑞
SZSE · Healthcare · C 制造业 · CN
CNY 7.14
−1.65%Year over year
Reported trailing growth
- Revenue
- +61.4%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +122.4%
- Operating cash flow
- +138.8%
Forward estimates
Based on analyst estimates
- Revenue
- +22.7%
- EBITDA
- +296.9%
- EPS
- +230.9%
Three-year CAGR
- Revenue
- -12.9%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -19.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026